We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
QLGN

Price
3.62
Stock movement down
-0.06 (-2.92%)
Company name
Qualigen Therapeutics Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
3.10M
Ent value
7.17M
Price/Sales
-
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-0.90%
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-68.35%
1 year return
-83.09%
3 year return
-79.36%
5 year return
-76.85%
10 year return
-70.63%
Last updated: 2025-09-15

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

QLGN does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book-
EV to Sales-

FINANCIALS

Per share

Loading...
Per share data
Current share count1.70M
EPS (TTM)-20.29
FCF per share (TTM)-25.08

Income statement

Loading...
Income statement data
Revenue (TTM)0.00
Gross profit (TTM)-1.12M
Operating income (TTM)-6.70M
Net income (TTM)-7.87M
EPS (TTM)-20.29
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash388.15K
Net receivables1.30M
Total current assets2.31M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets2.31M
Accounts payable1.64M
Short/Current long term debt1.43M
Total current liabilities4.45M
Total liabilities4.45M
Shareholder's equity-2.14M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-9.73M
Capital expenditures (TTM)4.00
Free cash flow (TTM)-9.73M
Dividends paid (TTM)87.60K

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-340.29%
Return on Invested Capital1113.88%
Cash Return on Invested Capital1376.92%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open1.85
Daily high1.88
Daily low1.82
Daily Volume11K
All-time high597500.00
1y analyst estimate5.00
Beta-0.17
EPS (TTM)-20.29
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
QLGNS&P500
Current price drop from All-time high-100.00%-1.46%
Highest price drop-100.00%-56.47%
Date of highest drop21 Aug 20259 Mar 2009
Avg drop from high-90.34%-10.99%
Avg time to new high1278 days12 days
Max time to new high2555 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
QLGN (Qualigen Therapeutics Inc) company logo
Marketcap
3.10M
Marketcap category
Small-cap
Description
Qualigen Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of treatments for adult and pediatric cancer. The company's lead program is QN-302, an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor, which is in Phase I clinical trial for the treatment of pancreatic cancer and other solid tumors. It is also developing Pan-RAS that is in preclinical stage for the treatment of advanced solid tumors. The company was founded in 1996 and is based in Carlsbad, California.
Employees
0
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...